Mithra Pharmaceuticals S.A. (MITRA)의 가격은 얼마입니까?

Mithra Pharmaceuticals S.A. (MITRA)의 가격은 $0.25620952입니다.

Mithra Pharmaceuticals S.A. (MITRA)의 시가 총액은 무엇입니까?

Mithra Pharmaceuticals S.A. (MITRA)의 시가 총액은 $17.14M입니다.

Mithra Pharmaceuticals S.A. (MITRA) PER

Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège, Belgium, specializes in the creation, production, and worldwide commercialization of advanced therapeutic solutions. The company's core focus areas include contraception, the management of menopause, and treatments for hormone-dependent cancers. Its robust development pipeline features Estelle, a combined oral contraceptive that has successfully concluded Phase III clinical trials, and Donesta, an estetrol-based oral hormone treatment currently undergoing Phase III development for menopausal symptoms. Mithra's product portfolio also encompasses Myring, a hormonal contraceptive vaginal ring; Tibelia, a therapy designed to address both menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant targeting prostate and breast cancers, as well as various benign gynecological conditions. Furthermore, the company markets NEXTSTELLIS, an established oral contraceptive pill. Their offerings span diverse pharmaceutical formats, including polymeric devices, implants, sterile injectable medications, and hormonal tablets.

연도	P/E 비율	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

P/E 비율

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	P/E 비율	P/E 비율 차이	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.29	-	IN

회사

P/E 비율

P/E 비율 차이

국가